Elizabeth C Verna Selected Research

Infections

1/2022	Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).
1/2022	White paper on antimicrobial stewardship in solid organ transplant recipients.
1/2021	Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.
1/2021	American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
10/2019	Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.
1/2019	Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.
10/2018	Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.
1/2018	Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.
12/2017	Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
2/2017	Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth C Verna Research Topics

Disease

33	Fibrosis (Cirrhosis) 01/2022 - 11/2008
21	End Stage Liver Disease 11/2022 - 08/2008
17	Infections 01/2022 - 11/2006
15	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2012
14	Liver Diseases (Liver Disease) 01/2021 - 08/2011
12	COVID-19 08/2021 - 01/2020
12	Hepatitis C 01/2019 - 08/2008
11	Neoplasms (Cancer) 04/2022 - 09/2008
8	Frailty 01/2022 - 01/2019
7	Non-alcoholic Fatty Liver Disease 11/2021 - 11/2008
6	Hepatitis 04/2020 - 07/2012
5	Chronic Renal Insufficiency 01/2022 - 07/2012
4	Ascites 10/2021 - 12/2017
4	Hepatitis B 09/2019 - 07/2012
3	Diarrhea 08/2022 - 09/2010
3	Portal Hypertension 01/2022 - 12/2008
3	Alcoholic Hepatitis 01/2022 - 01/2018
3	Hypertension (High Blood Pressure) 11/2021 - 03/2015
3	Autoimmune Hepatitis 11/2021 - 11/2011
3	Obesity 12/2019 - 11/2008
3	Renal Insufficiency (Renal Failure) 12/2018 - 06/2011
3	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 09/2012
3	Chronic Hepatitis C 10/2017 - 05/2012
3	Hepatorenal Syndrome 04/2013 - 04/2010
2	Acute-On-Chronic Liver Failure 01/2022 - 12/2020
2	Kidney Diseases (Kidney Disease) 01/2022 - 04/2013
2	Peritonitis 01/2022 - 12/2017
2	Diabetes Mellitus 01/2021 - 01/2021
2	Disease Progression 01/2020 - 04/2015
2	Colitis 12/2017 - 09/2010
2	Insulin Resistance 05/2016 - 11/2008
2	Cholangitis 12/2013 - 04/2013
2	Edema (Dropsy) 12/2013 - 04/2010
2	Crohn Disease (Crohn's Disease) 11/2011 - 09/2010
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2021
1	Pre-Eclampsia (Preeclampsia) 12/2021
1	Celiac Disease (Celiac Sprue) 11/2021
1	Hemorrhage 10/2021
1	Hydrothorax 10/2021
1	Residual Neoplasm 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Lung Injury 11/2020
1	Coinfection 11/2020
1	Biliary Atresia 04/2020

Drug/Important Bio-Agent (IBA)

11	SodiumIBA 11/2022 - 04/2010
8	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2006
6	Biomarkers (Surrogate Marker)IBA 11/2020 - 04/2013
4	CreatinineIBA 01/2022 - 06/2011
4	BilirubinIBA 10/2021 - 10/2017
4	Lipocalin-2IBA 01/2018 - 09/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2010
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2021 - 02/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2014
3	AlbuminsIBA 01/2020 - 08/2015
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 09/2014
2	EnzymesIBA 04/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2016
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 10/2021
2	Glutens (Glutelin)IBA 11/2021 - 12/2016
2	Calcineurin InhibitorsIBA 12/2018 - 06/2011
2	Basiliximab FDA Link 12/2018 - 06/2011
2	SteroidsIBA 10/2018 - 02/2014
2	TransferasesIBA 01/2018 - 03/2015
2	Ribavirin (Virazole)FDA LinkGeneric 10/2017 - 09/2014
2	Triglycerides (Triacylglycerol)IBA 05/2016 - 11/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2016 - 11/2008
2	LipidsIBA 05/2016 - 11/2008
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2015 - 09/2014
2	telaprevirIBA 08/2015 - 09/2014
2	Immunoglobulins (Immunoglobulin)IBA 04/2013 - 07/2012
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	8-hydroxyguanineIBA 04/2022
1	NADP (NADPH)IBA 04/2022
1	DNA Repair EnzymesIBA 04/2022
1	Rifaximin (L 105)FDA Link 01/2022
1	GliadinIBA 11/2021
1	TransglutaminasesIBA 11/2021
1	AntibodiesIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 11/2020
1	Cystatin CIBA 01/2020
1	remdesivirIBA 01/2020

Therapy/Procedure

65	Liver Transplantation 09/2022 - 11/2006
26	Therapeutics 08/2022 - 11/2006
10	Transplantation 01/2021 - 11/2006
4	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 12/2008
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 01/2021
2	Renal Dialysis (Hemodialysis) 01/2022 - 06/2011
1	Length of Stay 08/2022
1	Catheters 01/2022
1	Cesarean Section (Caesarean Section) 12/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Hepatic Portoenterostomy 04/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020
1	Kidney Transplantation 01/2020